Photo By Jacoplane (well, his parents anyway) - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=1276885
Coagulopathy occurs when bleeding is continuous and there is no identifiable source. Abnormal laboratory results depend on the cause and can include:
Increased prothrombin time
Increased partial thromboplastin time
Decreased platelets
Decreased fibrinogen level
Increased fibrin degradation products
Prolonged bleeding time
Causes of coagulopathies can include idiopathic or immune thrombocytopenic purpura, von Willebrand disease (vWD), and DIC.
Idiopathic or immune thrombocytopenic purpura (ITP) is an autoimmune disorder. The antiplatelet antibodies decrease the lifespan of the platelets. It is often discovered with prenatal screening of platelets on the CBC done in the first and second trimester.
Diagnostic Findings
Thrombocytopenia
Capillary fragility
Increased bleeding time.
Nursing Care
Control of platelet stability
Corticosteroids or IV immunoglobulin if diagnosed in pregnancy
Platelet transfusions
In some cases, a splenectomy may be needed
von Willebrand disease (vWD) is a type of hemophilia. It is a deficiency or defect in a blood-clotting protein called von Willebrand factor (vWF).
Signs and Symptoms
Recurrent bleeding episodes
Laboratory Results
Prolonged bleeding time
Prolonged partial thromboplastin time
Decreased vWF antigen levels
Decreased factor VIII immunological
Coagulation-promoting activity
The inability of platelets to react to various stimuli
Nursing Care
IV administration of desmopressin (DDAVP)
Concentrates of factor VIII (Humate-P or Alphanate)
Venous thromboembolism (VTE) results from the formation of a blood clot or clots inside a blood vessel and is caused by inflammation (thrombophlebitis) or partial obstruction of the vessel. Three thromboembolic conditions are of concern in the postpartum period:
Superficial venous thrombosis: Involvement of the superficial saphenous venous system
Deep venous thrombosis (DVT): Occurs most often in the lower extremities; involvement varies but can extend from the foot to the iliofemoral region
Pulmonary embolism (PE): Complication of DVT that occurs when part of a blood clot dislodges and is carried to the pulmonary artery, where it occludes the vessel and obstructs blood flow to the lungs
Incidence and Etiology
Primary:
Venous stasis
Hypercoagulation
Photo By Laboratoires Servier - This file was made available with support from the Helpdesk at the Content Partnerships Hub. The Helpdesk provides hands-on support to community members working with content partnerships.Smart Servier website: Cardiovascular system, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=127935684
Risk Factors
Cesarean birth
Obesity
Immobility
Malignancy
Chronic medical
Operative vaginal birth
History of venous thrombosis
PE
Varicosities
Maternal age older than 35 years
Multiparity
Smoking
Preeclampsia
Hemorrhage
Postpartum infection
Clinical Manifestations
Superficial venous thrombosis characterized by:
Pain and tenderness in the lower extremity
Warmth, redness, and an enlarged, hardened vein over the site of the thrombosis
Acute PE results from dislodged deep vein thrombi. Presenting symptoms are dyspnea and chest pain.
Other signs of PE include:
Tachypnea (more than 20 breaths/min)
Tachycardia (more than 100 beats/min)
Apprehension
Cough
Hemoptysis
Elevated temperature
Sweating
Syncope
There is no validated clinical prediction rule for DVT in pregnant women.
Diagnostics to determine PE:
The safety of D-dimer testing during pregnancy has not been validated
Echocardiographic abnormalities may be seen in the right ventricular size or function
Ventilation-perfusion
Spiral computed tomography scan
Magnetic resonance angiography
Pulmonary arteriogram
Superficial venous thrombosis is treated with analgesia, support from elastic compression stockings, heat, and rest.
DVT is treated with IV anticoagulant therapy, bed rest, affected leg elevated, analgesia. After the symptoms have decreased, elastic compression is used.
Acute PE is an emergent situation that requires prompt treatment.
Guzman, R.E., Hughes, A., Kiskaddon, A., Fort, P., & Betensky, M. (2023). Thrombosis in the Neonatal Intensive Care Unit. Neoreviews, 24(6): e356-369. https://publications.aap.org/neoreviews/article-abstract/24/6/e356/191326/Thrombosis-in-the-Neonatal-Intensive-Care-Unit?redirectedFrom=fulltext
Klaassen, R.J., & Halton, J.M., (2002). The Diagnosis and Treatment of vonWillebrand Disease in Children. Paediatrics and Child Health, 7(4): 345-349. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794822/
Sabih, A. & Babiker, H.M. (2023, August 28). Von Willebrand Disease. NIH StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK459222/
Sillers, L., VanSlambrouck, C., & Lapping-Carr, G. (2015), Neonatal thrombocytopenia: Etiology and Diagnosis. Pediatric Annals, 44(7): e175-180. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107300/